Compare COYA & HYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | HYNE |
|---|---|---|
| Founded | 2020 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 118.5M |
| IPO Year | 2022 | N/A |
| Metric | COYA | HYNE |
|---|---|---|
| Price | $4.47 | $14.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 101.5K | 25.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,554,061.00 | N/A |
| Revenue This Year | $69.95 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.94 | $13.56 |
| 52 Week High | $7.75 | $14.85 |
| Indicator | COYA | HYNE |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 37.86 |
| Support Level | $4.50 | $14.01 |
| Resistance Level | $5.21 | $14.85 |
| Average True Range (ATR) | 0.27 | 0.26 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 22.00 | 10.42 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.